Economics of Switching to Second-Line Antiretroviral...

Value in Health 2011 Vol. 14; Iss. 8

Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa: Estimates Based on DART Trial Results and Costs for Uganda and Kenya

Kit N. Simpson, Robert W. Baran, Stephanie E. Kirbach, Birgitta Dietz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.06.011
File:
PDF, 736 KB
english, 2011
Conversion to is in progress
Conversion to is failed